Figure 2.

Prognostic evaluation of the five‐mRNA signature in pediatric Wilms tumor patients. (a) The distribution of mRNA‐related survival risk score. (b) The distribution of mRNA‐related survival time. (c) Gene expression heatmap of five identified genes between high‐risk and low‐risk groups. (d) Kaplan–Meier survival curve analysis for overall survival of pediatric Wilms tumor patients between low‐ and high‐risk groups. (e) Receiver operating characteristic (ROC) curve indicated that the area under receiver operating characteristic of 5‐mRNA model was 0.821. (f) Bootstrap test with 500 times was used to perform the internal validation indicated that the area under receiver operating characteristic of 5‐mRNA model was 0.822